Shared Flashcard Set

Details

Winter Therapeutics Exam #2 - Osteoarthritis
n/a
23
Pharmacology
Graduate
01/13/2010

Additional Pharmacology Flashcards

 


 

Cards

Term
Osteoarthritis (OA)
Definition
disease of localized joints associated with deterioration of cartilage & 2ndary changes in underlying bone; causes pain & impairs fcn; leads to joint pain, stiffness, swelling; most common arthritic disorder; prevalence increases with age; more common in men <45 yrs old but more common in women >45 yrs old
Term
Pathophysiology of OA
Definition
cartilage water content increases --> changes glycosaminoglycans leading to loss of proteoglycans, reducing proteoglycans aggregates; Result: destruction of cartilage, structural changes in bone; Consequences: pain, decreased functioning & mobility
Term
Clinical Presentation of OA
Definition
PAIN: dull, aching, with joint activity; joint stiffness (in AM, lasts 30 min); inflammation (localized to affected joint); Rest relieves pain, movement relieves stiffness; Heberden's nodes - bony enlargements of DIP & PIP joints; Loss of range of motion; Joint tenderness; crepitus; Affects knees, hip, DIP, PIP, lumbar vertebrae
Term
Risk Factors for Developing OA
Definition
obesity; repetitive joint stress, overuse; trauma to joint, loss of ligament integrity, damage to meniscus; Age (>50 yrs); family hx; Usually does not occur in pts w/ osteoporosis
Term
Treatment Goals for OA
Definition
relieve pain & joint stiffness; maintain and/or improve joint mobility; limit functional impairment; minimize ADRs of therapy; Maintain or improve pts quality of life; Educate pt, family, caregivers
Term
Nonpharm Treatment of OA
Definition
Patient education; Social support services; Weight loss; Aerobic & muscle strengthening exercises; Heat/cold therapy; Weight loss; Physical therapy; Provide assistive ambulatory devices (canes, crutches); Occupational therapy; Surgery - severe pain refractory to convetional therapy
Term
acetaminophen (APAP, Tylenol)
Definition
1st line analgesic; Tx of mild-moderate pain of OA; MoA: acts in CNS, inhibits prostaglandin synthesis; Dose: 325-650 mg q4-6 hrs or 1000 mg 3-4x/day, MAX = 4 g/day; Take on scheduled basis (NOT PRN); Avoid if chronic EtOH abuse (MAX = 2.5 g/day); D-D interactions: warfarin (monitor INR); Monitor: LFTs, renal fcn
Term
aspirin (ASA)
Definition
MoA: inhibits prostaglandin synthesis; Dose: 325-650 mg q4-6 hrs, MAX = 3.6 g/day; ADRs: GI upset (Take w/ food, or EC), tinnitus (sign of toxicity); Precautions: anticoagulant tx, GI bleed, liver dx; Monitor: CBC, LFTs
Term
NSAIDs - ibuprofen [Advil, Motrin], naproxen [Aleve, Naprosyn], nabumetone [Relafen], diclofenac [Voltaren], meloxicam [Mobic]
Definition
MoA: inhibit prostaglandin synthesis thru inhibition of COX-1 & COX-2; ADRs: GI effects (nausea, dyspepsia, abd pain), duodenal & gastric ulceration (Take with food to minimize); Precautions: renal dx, GERD, PUD, HF; D-D ix: anticoagulants, ASA, other similar drugs, ACE-Is, ARBs, Li; Monitor: CBC, LFTs, renal fcn
Term
Risk Factors for GI events 2ndary to NSAIDs
Definition
age >65 yrs; comorbidities; oral glucocorticoids; history of PUD; hx of upper GI bleed; Pt on Anticoagulants; Length of time on drug, high doses
Term
naproxen [Aleve, Naprosyn]
Definition
250-500 mg BID; MAX = 1500 mg/day
Term
ibuprofen [Advil, Motrin]
Definition
400 mg TID - 800 mg QID; MAX = 4 g/day
Term
diclofenac [Voltaren]
Definition
50 mg BID-TID/day; MAX = 200 mg/day
Term
meloxicam [Mobic]
Definition
7.5 - 15 mg daily
Term
nabumetone [Relafen]
Definition
500 - 1,000 mg qdaily-BID
Term
celecoxib [Celebrex]
Definition
100 mg BID - 200 mg daily; MoA: inhibits COX-2 enzyme only; Tx: moderate-severe pain, less GI toxicity does not afect platelet aggregation; Monitor: CBC, renal fcn, liver fcn, BP; Concern regarding CVD; Caution: sulfa allergy
Term
Strategies to prevent GI bleeds when using NSAIDs
Definition
take w/ food; use COX-2 inhibitor or more COX-2 selective NSAID (meloxicam, nabumetone, etodolac); Monitor CBC yearly; Use NSAID in combo w/ GI protective med (PPI, misoprostol)
Term
capsaicin
Definition
derived from hot peppers; MoA: inhibits release of substance P in periphery, decreases transmission of painful stimuli; ADRs: burning, stinging, erythema at site; Dose: Take 2-4 wks for max benefit, take regularly (Apply 2-4 times/daily)
Term
glucocorticoids - methylprednisolone acetate (Medrol), triamcinolone hexacetonide
Definition
intraarticular injection; effective for knee OA, local inflammation or joint effusion, SHORT TERM; Use infrequently (4-6 month intervals, no more than 3-4 injections/yr); Administer physician's office; short term pain relief, use as adjunct
Term
intraarticular hyaluronic acid
Definition
intraarticular injection; for moderate-severe pain w/ ADR or C/I to APAP, NSAIDs, & COX-2 inhibitors or unable to use glucocorticoids; MoA: provides lubrication & shock absorbency in joint, anti-inflammatory; Regimen: 20 mg weekly x 5 wks, 16 mg weekly x 3 wks, 30 mg weekly x 3 wks; Pain relief occurs slowly, lasts up to 6 months; Indication: OA of knee only; HIGH COST; ADRs: pain @ injection site, transient joint pain, swelling
Term
tramadol [Ultram]
Definition
centrally acting analgesic, opioid-like; Dose: 50-100 mg q4-6 hrs, MAX = 400 mg/day, if >75 years old = 300 mg/day; ADRs: sedation, confusion, urinary incontinence, constipation; Dose adjusted to q12 hrs dosing if CrCl < 30 mL/min; abuse potential; Tx: moderate-severe pain if no response to APAP, NSAIDs, COX-2 inhibitors
Term
narcotic/analgesic combos - propoxyphene/APAP (Darvocet), hydrocodone/APAP (Vicodin, Lortab)
Definition
Tx: moderate-severe pain if no response/ADR/CI to APAP, NSAIDs, COX-2 inhibitors & tramadol; ADRs: constipation, dizziness, sedation, confusion; Avoid in elderly; Use low doses
Term
glucosamine sulfate
Definition
MoA: rebuild cartilage that is damaged, decrease cartilage loss, relieves OA sx, may slow dx progression, improves pain sx & functionality; Dose: 1500mg/1200 mg/day TID; ADRs: increases INR, GI upset, nausea; NOT FDA regulated
Supporting users have an ad free experience!